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Background: Central renin angiotensin system has an important role on the cerebral microcirculation and 
metabolism. Our previous work showed that inhibition of angiotensin converting enzyme (ACE) activity prior to 
induction of ischemia protected the brain from severe ischemia/reperfusion (I/R) injuries. This study evaluated the 
impacts of post-ischemic inhibition of ACE, enalapril, on brain infarction in normotensive rats. Methods: Rats 
were anesthetized with chloral hydrate (400 mg/kg). Focal cerebral ischemia was induced by 60-min intraluminal 
occlusion of right middle cerebral artery (MCA). Intraperitoneal injection of enalapril (0.03 or 0.1 mg/kg) was done 
after MCA reopening (reperfusion). Neurological deficit score (NDS) was evaluated after 24 h and the animals 
randomly assigned for the assessments of infarction, absolute brain water content (ABWC) and index of brain 
edema. Results: Severe impaired motor functions (NDS = 2.78 ± 0.28), massive infarction (cortex = 214 ± 19 mm3, 
striatum = 86 ± 5 mm3) and edema (ABWC = 83.1 ± 0.46%) were observed in non-treated ischemic rats. Non-
hypotensive dose of enalapril (0.03 mg/kg) significantly reduced NDS (1.5 ± 0.22), infarction (cortex = 102 ± 16 
mm3, striatum = 38 ± 5 mm3) and edema (ABWC = 80.9 ± 0.81%). Enalapril at dose of 0.1 mg/kg significantly 
lowered arterial pressure could not improve NDS (2.0 ± 0.45) and reduce infarction (cortex = 166 ± 26 mm3, 
striatum = 71 ± 11 mm3). Conclusion: Post-ischemic ACE inhibition in the normotensive rats without affecting 
arterial pressure protects the brain from reperfusion injuries; however, this beneficial action is masked by 
hypotension. Iran. Biomed. J. 16 (4): 202-208, 2012 
 





schemic brain injury is resulting from a complex 
sequence of pathophysiological events that is 
developed with time and space [1]. The extent of 
tissue damage occurring during stroke depends on both 
the duration and the intensity of focal cerebral ischemia 
[2]. Ischemic brain edema occurring during stroke,  per 
se, is life threatening due to augmentation of 
intracranial pressure and herniation [1], and its 
conjunction with cerebral infarction intensifies the 
primary complications of  ischemia injuries [3]. Pre-
ischemic inhibition of angiotensin converting enzyme 
(ACE), using enalapril as ACE inhibitor, reduces brain 
edema and prevents the brain from severe ischemia/ 
reperfusion (I/R) injury in normotensive rats [4]. Now 
the question is whether these beneficial effects can be 
seen after stroke? 
Some evidences exist about the role of ACE activity 
and angiotensin II (Ang II) in ischemic neuronal injury 
[5]. It is proposed that inhibition of the central renin-
angiotensin system might be valuable not only in 
reducing the occurrence of stroke but also in alleviating 
neuronal injuries after stroke [6]. Recent clinical 
studies have revealed that some ACE inhibitors, which 
are used as anti-hypertensive drugs, diminish the risk 
and the severity of secondary attacks of the stroke [7, 
8]. Previously, we showed that pre-ischemic treatment 
of normotensive rats with non-hypotensive dose of 
enalapril, an ACE inhibitor, improved neurological 
motor activity and concomitantly reduced cerebral 
edema and infarction [4]. As far as literature search is 
concerned, few studies have tackled the effectiveness 
of post-ischemic inhibition of ACE activity in reducing 
cerebral I/R injuries [7]. Therefore, this study was 
designed to evaluate the effects of ACE inactivation by 
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administration of enalapril after termination of middle 




MATERIALS AND METHODS 
 
Male normotensive Sprague Dawley rats (280-320 g) 
were obtained from Central Animal House Facility of 
Shiraz University of Medical Sciences (Shiraz, Iran). 
All protocols of the study were approved by the 
Institutional Animal Ethics Committee of the 
University, which follows the NIH guidelines for care 
and use of animals. Animals were housed at room 
temperature of 22-24°C, humidity of 40-60% and light 
period of 07.00-19.00 with controlled environments. 
Animals were food fasted overnight prior to surgery 
but had free access to water ad libitum. Anesthesia was 
made by intraperitoneal injection (i.p.) of chloral 
hydrate (400 mg/kg). Core body temperature was 
measured by a rectal probe connected to a thermistor 
and maintained at 37 ± 0.5ºC with a heating pad.  
 
Recordings of arterial blood pressure and regional 
cerebral blood flow (rCBF). After induction of 
anesthesia, four rats of each group were randomly 
selected and cannulation of posterior tail artery was 
performed for continuous recording of arterial blood 
pressure and taking blood samples. In the same rats, 
laser Doppler flowmetry (AD Instrument, model: 
ML191, Australia) was performed as described 
previously [9], to continuously record the rCBF of the 
areas of the right hemisphere that were nourished from 
the right MCA.  
 
Induction of transient focal cerebral ischemia. 
Right MCA occlusion was carried out by intraluminal 
filament method described by Longa et al. [10] and 
modified by Panahpour et al. [4]. In short, the right 
common carotid artery was exposed through a midline 
neck incision. Through the external carotid artery, a 
surgical nylon thread (3-0, coated with poly-L-lysine) 
was placed in the internal carotid artery and gently 
advanced up until feeling a resistance and seeing a 
sharp decline in the blood flow trace. MCA occlusion 
terminated after 60-min ischemia by gently pooling out 
the thread. After re-establishment of the blood flow of 
the ischemic region, all the incisions were sutured, the 
animals were allowed to recover from anesthesia, and 
returned to a warm cage for recuperation during 24 h 
reperfusion period. 
 
Experimental protocol and groups. Sham (n = 16) 
rats underwent the surgery at the neck region and 
received a single i.p. injection of the vehicle (1 ml/kg 
distilled water) without being exposed to MCA 
occlusion. 
  
Control ischemia (CI). After neck surgery, similar 
group, rats (n = 12) underwent 60 MCA occlusion. A 
single i.p. injection of the vehicle (1 ml/kg distilled 
water) was done after the start of MCA reopening 
(reperfusion).   
 
Post-ischemic enalapril treated -1 (PIEnT-1). Rats 
of this group (n = 12) were treated similar to CI, but 
received a single i.p. injection of 0.03 mg/kg enalapril 
(Sigma Chemicals, UK). 
 
Post-ischemic enalapril treated -2 (PIEnT-2). Rats 
of this group (n = 11) were treated similar to PIEnT-1, 
but the dose of enalapril was increased to 0.1 mg/kg. 
The number of animals presented for each group was 
the number of rats that survived during 24 h 
reperfusion period. The obtained data of the animals 
that died during 24 h reperfusion period were excluded 
from the study. The number of deceased animals with 
respect to the total number of rats in each group was 
regarded as the percent of mortality rate, which was 
0%, 25%, 25% and 31.3% for sham, CI, PIEnT-1 and 
PIEnT-2 groups, respectively.  
 
Evaluation of neurological outcome. Behavioral 
tests were performed in blinded fashion 24 h after the 
start of the reperfusion (MCA reopening) in rats 
survived from ischemic trauma and at comparable 
periods in the sham group. A five-point grading scale 
of neurological deficit score (NDS) test was carried out 
to evaluate the neurological outcome [11]. After 
evaluation of motor neuron activity, rats of each group 
were randomly divided into two subgroups to quantify 
the extent of cerebral infarction volumes and brain 
edema. 
 
Quantification of cerebral lesions. Animals were 
deeply anesthetized and guillotined. The brain was 
immediately removed, cleaned and for solidification, 
immersed in 4°C cold normal saline and kept in a 
refrigerator for 5 min. Frontal sections of 2-mm thick 
slices were prepared using a brain matrix and stained 
with triphenyl-tetrazolium chloride as described 
previously [11, 12]. In this staining technique, non-
ischemic brain regions were colored red by converting 
triphenyl-tetrazolium chloride to a deep red formazan 
compound and ischemic areas remained white due to 
failure of this conversion (Fig. 1). After staining, the 
slices were photographed and their infarction areas 
were determined with computer based NIH image 
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Fig. 3. Regional cerebral blood flow (rCBF) in control ischemic (CI) rats received the vehicle (n = 5) and ischemic rats received 
enalapril at doses of 0.03 mg/kg (PIEnT-1, n = 4) and 0.1 mg/kg (PIEnT-2, n = 5) before and during MCAO as well as during 
reperfusion period. Animals received enalapril at the beginning of reperfusion. Values are mean ± S.E.M. *significantly different 
(P<0.05) from control ischemia, #significantly different (P<0.05) from PIEnT-1. 
 
 
Physiological parameters. All physiological 
parameters measured during the experiment, such as 
arterial blood gas, blood pH, blood glucose and body 
temperature were at normal physiological range and 
inter- and intra-group comparisons indicated no 
significant differences among their proper values. 
 
Evaluation of neurological deficit score. The NDS 
of ischemic rats have been presented in Figure 4. NDS 
of CI group (2.78 ± 0.28) was significantly higher than 
both sham and PIEnT-1 groups (1.5 ± 0.22). However, 
NDS of PIEnT-2 group (2.0 ± 0.45) was not 
significantly different from CI group, but was 
significantly higher than sham group (Fig. 4). 
 
Assessment of cerebral infarct volumes. Figure 1 is 
a photograph of the coronal sections of rat brains 
stained with triphenyl-tetrazolium chloride. The 
uniform dark red color of the slices of the right and the 
left hemispheres of sham is an induction that 
anesthesia, neck surgery or other surgical maneuvers 
per se did not provoke brain injury. This was also true 
in the left hemispheres (non-lesioned hemispheres) of 
ischemic rats, meaning that 60-min right MCA 
occlusion did not affect the left side. The appearance of 
white color combined with dark red color areas in the 
right hemispheres of ischemic rats indicated that 60-
min right MCA occlusion induced different 
magnitudes of infarctions without affecting the left 
hemispheres. MCA occlusion of the right hemispheres 
in the ischemic rats induced various intensities of 
infarctions. In addition, quantitative comparisons of 
these intensities indicated that 60-min MCA occlusion 
provoked severe infarctions in the cortical and 
subcortical regions of CI group. Enalapril could reduce 
the size of infarction about 53% at dose of 0.03 mg/kg 
but not at dose of 0.1 mg/kg (Fig. 1). Quantitative 
comparisons of cerebral infarction volumes have been 
shown in Figure 5. The sham-operated rats had no 
cerebral infarctions and the total cerebral infarct 
volume of PIEnT-1 (141 ± 21 mm3) was significantly 
lower than either CI (301 ± 23 mm3) or PIEn-T2 (237 
± 36 mm3). More specifically, comparison of cortical 
infarction of ischemic rats indicated that there was a 
substantial reduction in their infarct volumes when the 
rats were treated with enalapril at 0.03 mg/kg but not at  
 
 
      
 
Fig. 4. Neurological deficit score in sham rats (n = 16), 
control ischemic (CI) rats (n = 12) and ischemic rats received 
enalapril at doses of 0.03 mg/kg (PIEnT-1, n = 12) and 0.1 
mg/kg (PIEnT-2, n = 11) during reperfusion period. Values are 
mean ± S.E.M. *significant difference (P<0.05) from ischemic 
control rats, **significant difference (P<0.01) from sham 
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Brain edema is life-threatening complication of 
cerebral ischemia and one of the major determinants of 
patient’s survival after the first few hours of stroke [3]. 
Some investigators that showed long-term ACE 
inhibition has a correlation with edema and mortality 
rate [27-30]. This study shows that enalapril in 
normotensive rat reduced edema of the ischemic 
hemispheres independent of arterial blood pressure 
changes. An earlier report also showed that enalapril 
reduces cerebral edema in stroke-prone hypertensive 
rats [31] and prevents stroke dysfunctions by 
diminishing hypertension in salt-loaded hypertensive 
rats [27]. In accordance with our findings, Porritt et al. 
[32] showed that the beneficial effects of ACE 
inhibition do not correlate with changes in blood 
pressure. Therefore, in our study, the reduced edema in 
the presence of normal blood pressure besides other 
mechanisms probably improves the re-establishment of 
microcirculation of the ischemic region and helps the 
repair of damages done during ischemia. In 
normotensive rats, post-ischemic inhibition of ACE 
with enalapril protected the brain from ischemic 
reperfusion injury. This protection was coincided with 
normal arterial pressure blood pressure, but was absent 
during hypotension.  
Therefore, the results of this study show that 
prevention of reduced arterial blood pressure is 
important in helping the non-hypertensive patients to 
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